ArticleBMC complementary medicine and therapies2021

Thymoquinone inhibited vasculogenic capacity and promoted mesenchymal-epithelial transition of human breast cancer stem cells.

Sanya Haiaty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.